<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">EPMA J</journal-id>
<journal-id journal-id-type="iso-abbrev">EPMA J</journal-id>
<journal-title-group>
<journal-title>The EPMA Journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">1878-5077</issn>
<issn pub-type="epub">1878-5085</issn>
<publisher>
<publisher-name>Springer International Publishing</publisher-name>
<publisher-loc>Cham</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29021833</article-id>
<article-id pub-id-type="pmc">5607054</article-id>
<article-id pub-id-type="publisher-id">118</article-id>
<article-id pub-id-type="doi">10.1007/s13167-017-0118-2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>What California sea lions exposed to domoic acid might teach us about autism: lessons for predictive and preventive medicine</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lahvis</surname>
<given-names>Garet Paul</given-names>
</name>
<address>
<phone>(503) 346 0820</phone>
<email>lahvisg@ohsu.edu</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9758 5690</institution-id><institution-id institution-id-type="GRID">grid.5288.7</institution-id><institution>Department of Behavioral Neuroscience, </institution><institution>Oregon Health &amp; Science University, </institution></institution-wrap>Portland, OR 97239 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>12</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>12</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>9</month>
<year>2017</year>
</pub-date>
<volume>8</volume>
<issue>3</issue>
<fpage>229</fpage>
<lpage>235</lpage>
<history>
<date date-type="received">
<day>7</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>8</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© European Association for Predictive, Preventive and Personalised Medicine (EPMA) 2017</copyright-statement>
</permissions>
<abstract id="Abs1">
<p id="Par1">Autism spectrum disorder (ASD) shares many biological and behavioral similarities with the deleterious effects of domoic acid (DA) exposure. DA is produced by marine algae and most commonly by species of <italic>Pseudo-nitzschia</italic>. Humans and marine mammals can be exposed to DA when they consume whole fish or shellfish. The mammalian fetus is highly sensitive to the deleterious effects of DA exposure. Both ASD and exposures to toxic levels of DA feature repetitive behaviors, challenges with social interaction, and seizures. They can also share a commonality in brain anatomy and function, particularly the balance between excitatory and inhibitory mechanisms. The current article is relevant to predictive, preventive, and personalized medicine for three reasons. First, shellfish consumption may be a risk factor for ASD and the regulatory limit for DA should be adjusted to prevent this possibility. Human contributions to increased algal production of DA in coastal waters should be identified and reduced. Second, evaluations of sentinel species wild and free-roaming in the environment, though typically outside the purview of biomedical research, should be much more fully employed to gain insights to risk factors for human disease. To better identify and prevent disease, biomedical researchers should study wild populations. Third, studies of DA exposure highlight the possibility that glutamate additives to processed foods may also have deleterious impacts on human brain development and behavior.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Domoic acid</kwd>
<kwd>Autism spectrum disorder</kwd>
<kwd>Glutamate</kwd>
<kwd>Behavior</kwd>
<kwd>Anatomy</kwd>
<kwd>Brain</kwd>
<kwd>Development</kwd>
<kwd>Predictive diagnosis</kwd>
<kwd>Targeted prevention</kwd>
<kwd>Population screening</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005798</institution-id>
<institution>Oregon Sea Grant, Oregon State University</institution>
</institution-wrap>
</funding-source>
<award-id>NA06OAR4170059</award-id>
<principal-award-recipient>
<name>
<surname>Lahvis</surname>
<given-names>Garet Paul</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© European Association for Predictive, Preventive and Personalised Medicine (EPMA) 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>